Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Germinated Brown rice enhanced n-3 PUFA metabolism in type 2 diabetes patients: A randomized controlled trial.

  • 2023-04
  • Clinical nutrition (Edinburgh, Scotland) 42(4)
    • Guanqiong Na
    • Jing Zhang
    • Dian Lv
    • Ping Chen
    • Xinyue Song
    • Fenfen Cai
    • Sicong Zheng
    • Wenting Wan
    • Yujuan Shan

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 112
Population
112 T2DM patients (61 female, 51 male)
Methods
Randomly divided into GBR intervention group (n=56) and control group (n=56); GBR group consumed 100 g/d GBR instead of equal refined grain for 3 months; control group maintained usual eating habits
Blinding
Open-label
Duration
3 months
Funding
Unclear
  • Large Human Trial

Background

Brown rice (BR) has been considered as a potential strategy in improving T2DM. However, there are a lack of population-based trials on the association of Germinated brown rice (GBR) and diabetes.

Aims

We aimed to explore the influence of GBR diet in T2DM patients for 3 months and whether this effect relates to serum fatty acids.

Methods

Two hundred and twenty T2DM patients have been enrolled and eligible subjects (n = 112, 61 female, 51 male) were randomly divided into GBR intervention group (n = 56) and control group (n = 56). Except those who lost follow-up and withdrew, final GBR group and control group consisted of 42 and 43 patients, respectively. Participants in GBR group were asked to consume 100 g/d GBR instead of equal refined grain (RG) for 3 months, while control group maintain their usual eating habits. A structured questionnaire was used for demographic information at baseline, and basic indicators were measured both at the beginning and end of the trail to evaluate plasma glucose and lipids levels.

Results

In GBR group, mean dietary inflammation index (DII) decreased, indicating GBR intervention retarded patient inflammation. Besides, glycolipid related parameters, including FBG, HbA1c, TC and HDL, were all significantly lower than those in control group. Excitingly, fatty acid composition was changed by intake of GBR, especially n-3 PUFA and n-3/n-6 PUFA rate were significantly increased. Moreover, subjects in GBR group had higher levels of n-3 metabolites, such as RVE, MaR1 and PD1, reducing inflammatory effect. In contrast, n-6 metabolites, like LTB4 and PGE2 which could promote inflammatory effect, were lower in GBR group.

Conclusion

We confirmed that diet with 100 g/d GBR for 3 months could really improve T2DM to some extent. This beneficial effect may be related to n-3 metabolites, namely inflammation changes.

Trial registration

ChiCRT-IOR-17013999, www.chictr.org.cn.

Research Insights

    Back to top